<?xml version="1.0" encoding="UTF-8"?>
<p>Recent pharmacovigilance studies have highlighted certain questions about the purported safety (non-teratogenic or carcinogenic) of parabens [
 <xref rid="B29-pharmaceutics-13-00387" ref-type="bibr">29</xref>]. Alternatives should therefore be found, especially in paediatric formulations. Antimicrobials are not necessary for parenteral formulations. The absence of parabens and benzoates in 85% of parenteral prescriptions suggests that administration of these excipients can be largely avoided [
 <xref rid="B36-pharmaceutics-13-00387" ref-type="bibr">36</xref>]. 
</p>
